{"name":"CPEX Pharmaceuticals Inc.","slug":"cpex-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nasulin","genericName":"Nasulin","slug":"nasulin","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Nasulin","genericName":"Nasulin","slug":"nasulin","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBQMUt1dTZUczN0N0JVbUZINjRWRldzeHZ0UGdCdFZjRi1VakY1a0I3a1loQng4cmdUVE55TFMzOFpON2ZXalVkZWF2RGc0VVgzU0gyWUd5ZUhQOE85ODNIQzVUY1RmLWRtM3BWS2ZBSDZDMVozN1pXdzFxWQ?oc=5","date":"2020-02-23","type":"pipeline","source":"ScienceDirect.com","summary":"Nasal drug delivery — Recent developments and future prospects - ScienceDirect.com","headline":"Nasal drug delivery — Recent developments and future prospects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNLTBOdU9VYjFycGZwcjlweTNLM00zaEdhbGdWN2RvbGhDUXRmR3ZVSExfcjd3eGFscmZEdnEzQVRtYmp4SE1LSWtPdS1fd3lLc2pZdE5FZmN2a2o0eGVJUm5xM3lhODY2eWRmVXozYUswXzUtVm1Ld0l0NGtLYmZ5Rm9vMzV5M2dxQ3RoWVgxbUE2UkdQZ3pGT0d4SHJrdzhGeVJUeDA4N05palNPeFY3MjZ2OA?oc=5","date":"2008-04-01","type":"pipeline","source":"Seacoastonline.com","summary":"Exeter firm to sell for $360 million - Seacoastonline.com","headline":"Exeter firm to sell for $360 million","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}